Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding to attract US ...

Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...

Stem cell therapy shows early promise for treating Parkinson's. Discover who is in the race to bring this breakthrough to ...

Biopharmas have been scaling back on AAV research for sometime now. Find out why and what's on the horizon for drug delivery ...

Learn how to optimize cold chain logistics for biotherapeutics in EMEA and overcome key challenges in delivery and regulation ...

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

With one of the most densely concentrated life sciences and biotech ecosystems in Europe, the Netherlands is home to numerous biotech and pharmaceutical companies, and also happens to be the ...

In the heat of the COVID-19 crisis, a wave of vaccine companies stepped into the spotlight with unprecedented speed and visibility. Riding a surge of public and private funding, they raced to develop ...

For decades, non-small cell lung cancer (NSCLC) stood as one of the formidable challenges in oncology, often diagnosed late and treated with limited options. But now, it looks like the therapeutic ...